Genetic loci modulating amyloid-beta levels in a mouse model of Alzheimer's disease

被引：31

作者：

Ryman, Davis ^{[1
,2
]}

Gao, Yuan ^{[2
]}

Lamb, Bruce T. ^{[1
,2
,3
]}

机构：

[1] Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA

[2] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA

[3] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA

来源：

NEUROBIOLOGY OF AGING | 2008年 / 29卷 / 08期

关键词：

APP; beta-amyloid; Abeta; Alzheimer; genetics; QTL; mouse; intercross;

D O I：

10.1016/j.neurobiolaging.2007.02.017

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

Genetic studies have demonstrated very high heritability for Alzheimer's disease (AD) risk in humans; however, these genetic contributions have proven extremely challenging to map in large studies of AD patients. Processing of the amyloid precursor protein (APP) to produce amyloid-beta (A beta) peptide is increasingly believed to be of central importance in AD pathogenesis. Intriguingly, mice from the C57BL/6J and DBA2/J inbred strains carrying the R1.40 APP transgene produce identical levels of unprocessed APP, but demonstrate significant, heritable differences in A beta levels. To identify specific loci responsible for the observed genetic control of A beta metabolism in this model system, we have performed a whole-genome quantitative trait locus (QTL) mapping experiment on a total of 516 animals from a C57BL/6J x DBA/2J intercross using a dense set of SNP genetic markers. Our studies have identified three loci on mouse chromosomes 1, 2, and 7 showing significant or suggestive associations with brain A beta levels, several of which contain regions syntenic to previous reports of linkage in human AD. (c) 2007 Elsevier Inc. All rights reserved.

引用

页码：1190 / 1198

页数：9

共 40 条

[1]

[Anonymous], 1998, Genetics and Analysis of Quantitative Traits (Sinauer)

[2] Results of a high-resolution genome screen of 437 Alzheimer's Disease families [J].

Blacker, D ;

Bertram, L ;

Saunders, AJ ;

Moscarillo, TJ ;

Albert, MS ;

Wiener, H ;

Perry, RT ;

Collins, JS ;

Harrell, LE ;

Go, RCP ;

Mahoney, A ;

Beaty, T ;

Fallin, MD ;

Avramopoulos, D ;

Chase, GA ;

Folstein, MF ;

McInnis, MG ;

Bassett, SS ;

Doheny, KJ ;

Pugh, EW ;

Tanzi, RE .

HUMAN MOLECULAR GENETICS, 2003, 12 (01) :23-32

[3] Role of complement in neurodegeneration and neuroinflammation [J].

Bonifati, Domenico Marco ;

Kishore, Uday .

MOLECULAR IMMUNOLOGY, 2007, 44 (05) :999-1010

[4]

Brich J, 2003, J NEUROSCI, V23, P187

[5] The low density lipoprotein receptor-related protein 1B retains β-amyloid precursor protein at the cell surface and reduces amyloid-β peptide production [J].

Cam, JA ;

Zerbinatti, CV ;

Knisely, JM ;

Hecimovic, S ;

Li, YH ;

Bu, GJ .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (28) :29639-29646

[6]

CHURCHILL GA, 1994, GENETICS, V138, P963

[7] The number of trait loci in late-onset Alzheimer disease [J].

Daw, EW ;

Payami, H ;

Nemens, EJ ;

Nochlin, D ;

Bird, TD ;

Schellenberg, GD ;

Wijsman, EM .

AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 66 (01) :196-204

[8] Complement Clq expression induced by Aβ in rat hippocampal organotypic slice cultures [J].

Fan, R ;

Tenner, AJ .

EXPERIMENTAL NEUROLOGY, 2004, 185 (02) :241-253

[9] Role of genes and environments for explaining Alzheimer disease [J].

Gatz, M ;

Reynolds, CA ;

Fratiglioni, L ;

Johansson, B ;

Mortimer, JA ;

Berg, S ;

Fiske, A ;

Pedersen, NL .

ARCHIVES OF GENERAL PSYCHIATRY, 2006, 63 (02) :168-174

[10] Complete ascertainment of dementia in the Swedish Twin Registry: the HARMONY study [J].